NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial, & Institute of Regulatory Science for Medical Device, & National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064, People's Republic of China.
Int J Nanomedicine. 2024 Jul 22;19:7415-7471. doi: 10.2147/IJN.S460047. eCollection 2024.
Cancer, as the foremost challenge among human diseases, has plagued medical professionals for many years. While there have been numerous treatment approaches in clinical practice, they often cause additional harm to patients. The emergence of nanotechnology has brought new directions for cancer treatment, which can deliver anticancer drugs specifically to tumor areas. This article first introduces the application scenarios of nanotherapies and treatment strategies of nanomedicine. Then, the noteworthy characteristics exhibited by biopolymer materials were described, which make biopolymers stand out in polymeric nanomedicine delivery. Next, we focus on summarizing the state-of-art studies of five categories of proteins (Albumin, Gelatin, Silk fibroin, Zein, Ferritin), nine varieties of polysaccharides (Chitosan, Starch, Hyaluronic acid, Dextran, cellulose, Fucoidan, Carrageenan, Lignin, Pectin) and liposomes in the field of anticancer drug delivery. Finally, we also provide a summary of the advantages and limitations of these biopolymers, discuss the prevailing impediments to their application, and discuss in detail the prospective research directions. This review not only helps readers understand the current development status of nano anticancer drug delivery systems based on biopolymers, but also is helpful for readers to understand the properties of various biopolymers and find suitable solutions in this field through comparative reading.
癌症作为人类疾病中的首要挑战,多年来一直困扰着医学专业人员。尽管临床实践中有许多治疗方法,但它们常常给患者带来额外的伤害。纳米技术的出现为癌症治疗带来了新的方向,可以将抗癌药物特异性地递送到肿瘤区域。本文首先介绍了纳米疗法的应用场景和纳米药物治疗策略。然后,描述了生物聚合物材料表现出的显著特点,这使得生物聚合物在聚合物纳米药物输送中脱颖而出。接下来,我们重点总结了五类蛋白质(白蛋白、明胶、丝素蛋白、玉米醇溶蛋白、铁蛋白)、九种多糖(壳聚糖、淀粉、透明质酸、葡聚糖、纤维素、褐藻胶、卡拉胶、木质素、果胶)和脂质体在抗癌药物输送领域的最新研究进展。最后,我们还总结了这些生物聚合物的优缺点,讨论了它们应用中存在的主要障碍,并详细讨论了未来的研究方向。本文综述不仅有助于读者了解基于生物聚合物的纳米抗癌药物输送系统的当前发展状况,还有助于读者通过比较阅读了解各种生物聚合物的性质,并在该领域找到合适的解决方案。
Int J Nanomedicine. 2024
Curr Top Med Chem. 2017
Int J Mol Sci. 2013-1-14
Eur J Pharm Biopharm. 2015-6
Nanomedicine (Lond). 2007-10
Curr Drug Deliv. 2015
Int J Biol Macromol. 2024-5
Front Immunol. 2025-3-10
Int J Nanomedicine. 2025-2-12
Int J Mol Sci. 2024-9-26
J Nanobiotechnology. 2024-2-29
Biomacromolecules. 2024-2-12
Adv Healthc Mater. 2023-12
Bioact Mater. 2023-8-8
Int J Pharm. 2023-8-25